| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2014 | VIROPHARMA INCORPORATED |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
$110,000 | |
| 2013 | VIROPHARMA INCORPORATED |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$200,000 | |
| 2013 | VIROPHARMA INCORPORATED |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$130,000 | |
| 2013 | VIROPHARMA INCORPORATED |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$110,000 | |
| 2013 | VIROPHARMA INCORPORATED |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$200,000 | |
| 2012 | VIROPHARMA INCORPORATED |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$100,000 | |
| 2012 | VIROPHARMA INCORPORATED |
2nd Quarter (Apr 1 - June 30) AMENDED |
$120,000 | |
| 2012 | VIROPHARMA INCORPORATED |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$100,000 | |
| 2012 | VIROPHARMA INCORPORATED |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$140,000 | |
| 2012 | VIROPHARMA INCORPORATED |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$190,000 |
| Firm | Filings | Expenses |
|---|---|---|
| VIROPHARMA INCORPORATED | 13 | $1,430,000 |
| Issue | Activities |
|---|---|
| Health Issues | 10 |
| Pharmacy | 3 |